635815112	635815112	CD	B-NP	O
|	|	NN	I-NP	O
HUCCGH	HUCCGH	NN	I-NP	O
|	|	NN	I-NP	O
48636446	48636446	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3462110	3462110	CD	B-NP	O
|	|	CC	I-NP	O
10/11/2004	10/11/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
MYOCARDIAL	MYOCARDIAL	NNP	I-NP	I-protein
INFARCTION	INFARCTION	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/4/2004	4/4/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/1/2004	6/1/2004	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
FLORENCIO	FLORENCIO	NNP	B-NP	O
LUGER	LUGER	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	NNP	B-NP	O
ILLNESS	ILLNESS	NNP	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
46-year-old	46-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
type	type	NN	B-NP	O
2	2	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
including	include	VBG	B-PP	O
the	the	DT	B-NP	O
father	father	NN	I-NP	O
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
MI	MI	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
of	of	IN	B-PP	O
51	51	CD	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
LM	LM	NN	B-NP	O
on	on	IN	B-PP	O
9/17	9/17	CD	B-NP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	B-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
at	at	IN	B-PP	O
an	an	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
at	at	IN	B-PP	O
4	4	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
on	on	IN	B-PP	O
1/15/04	1/15/04	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
developed	develop	VBD	B-VP	O
acute	acute	JJ	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
substernal	substernal	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
while	while	IN	B-SBAR	O
riding	ride	VBG	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
train	train	NN	I-NP	O
home	home	NN	I-NP	O
from	from	IN	B-PP	O
Mon	Mon	NNP	B-NP	O
Ph	Ph	NNP	I-NP	O
Pids	Pids	NNP	I-NP	O
The	The	DT	B-NP	O
pain	pain	NN	I-NP	O
radiated	radiate	VBN	B-VP	O
to	to	TO	B-PP	O
both	both	DT	B-NP	O
arms	arm	NNS	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
right	right	NN	B-NP	O
,	,	,	O	O
jaw	jaw	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
sweats	sweat	NNS	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
EKG	EKG	NN	I-NP	O
two	two	CD	B-NP	O
hours	hour	NNS	I-NP	O
later	later	RB	B-VP	O
showing	show	VBG	I-VP	O
marked	marked	JJ	B-NP	O
ST	ST	NN	I-NP	O
elevations	elevation	NNS	I-NP	O
in	in	IN	B-PP	O
V2	V2	NN	B-NP	O
and	and	CC	I-NP	O
V3	V3	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
aVL	aVL	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
reciprocal	reciprocal	JJ	B-NP	O
ST	ST	NN	I-NP	O
depressions	depression	NNS	I-NP	O
inferiorly	inferiorly	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
sublingual	sublingual	JJ	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NNP	B-NP	O
,	,	,	O	O
Integrilin	Integrilin	NNP	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Ettecile	Ettecile	NNP	I-NP	O
Valley	Valley	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
emergent	emergent	JJ	I-NP	O
PCI	PCI	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
type	type	NN	B-NP	O
2	2	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
controlled	control	VBN	B-VP	O
only	only	RB	B-ADVP	O
with	with	IN	B-PP	O
oral	oral	JJ	B-NP	O
hypoglycemics	hypoglycemic	NNS	I-NP	O
-LRB-	-LRB-	TO	B-PP	O
glyburide	glyburide	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
anxiety	anxiety	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Glyburide	Glyburide	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	FW	I-NP	O
ALLERGIES	ALLERGIES	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
recently	recently	RB	B-ADVP	O
with	with	IN	B-PP	O
stress	stress	NN	B-NP	O
relating	relate	VBG	B-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
place	place	NN	I-NP	O
of	of	IN	B-PP	O
work	work	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
expected	expect	VBN	I-VP	O
a	a	DT	B-NP	O
job	job	NN	I-NP	O
interview	interview	NN	I-NP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
MI	MI	NN	I-NP	O
one	one	CD	B-NP	O
year	year	NN	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
tobacco	tobacco	NN	B-NP	O
with	with	IN	B-PP	O
occasional	occasional	JJ	B-NP	O
alcohol	alcohol	NN	I-NP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
month	month	NN	I-NP	O
,	,	,	O	O
denies	deny	VBZ	B-VP	O
use	use	NN	B-NP	O
of	of	IN	B-PP	O
street	street	NN	B-NP	O
drugs	drug	NNS	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
and	and	CC	O	O
in	in	IN	B-PP	O
moderate	moderate	JJ	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
distress	distress	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
anxiety	anxiety	NN	B-NP	O
following	follow	VBG	B-PP	O
his	his	PRP$	B-NP	O
cath	cath	NN	I-NP	O
.	.	.	O	O

Vital	Vital	JJ	B-NP	O
Signs	Sign	NNS	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
temp	temp	NN	I-NP	O
of	of	IN	B-PP	O
100.2	100.2	CD	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
120/79	120/79	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
96	96	CD	B-NP	O
beats	beat	NNS	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
satting	satte	VBG	I-VP	O
at	at	IN	B-PP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
L	L	NN	I-NP	O
of	of	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
JVP	JVP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
9	9	CD	B-NP	O
cm	cm	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
carotids	carotid	NNS	I-NP	O
without	without	IN	B-PP	O
bruits	bruit	NNS	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
extraocular	extraocular	JJ	I-NP	O
motions	motion	NNS	I-NP	O
were	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
pupils	pupil	NNS	I-NP	O
were	be	VBD	B-VP	O
equal	equal	JJ	B-ADJP	O
,	,	,	O	O
round	round	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
reactive	reactive	JJ	B-ADJP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
,	,	,	O	O
S1	S1	NN	B-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
S4	S4	NN	I-NP	B-protein
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
had	have	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
breath	breath	NN	B-NP	O
sounds	sound	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
right	right	JJ	I-NP	O
base	base	NN	I-NP	O
with	with	IN	B-PP	O
crackles	crackle	NNS	B-NP	O
about	about	IN	B-PP	O
one-third	one-third	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
way	way	NN	I-NP	O
up	up	RP	B-PRT	O
on	on	IN	B-PP	O
that	that	DT	B-NP	O
side	side	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
left	left	JJ	I-NP	O
lung	lung	NN	I-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
abdomen	abdoman	NNS	I-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
nontender	nontender	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
nondistended	nondistended	JJ	B-ADJP	O
.	.	.	O	O

Bowel	Bowel	NN	B-NP	O
sounds	sound	NNS	I-NP	O
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	B-protein
had	have	VBD	B-VP	I-protein
2	2	CD	B-NP	I-protein
+	+	SYM	I-NP	O
pedal	pedal	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
pitting	pit	VBG	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Skin	Skin	NN	B-NP	O
:	:	:	O	O
Noted	Note	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
hypopigmented	hypopigmente	VBN	I-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
albinism	albinism	NN	B-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
additional	additional	JJ	I-NP	O
comment	comment	NN	I-NP	O
about	about	IN	B-PP	O
his	his	PRP$	B-NP	O
HEENT	HEENT	NN	I-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
legally	legally	RB	B-ADJP	O
blind	blind	JJ	I-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
most	most	JJS	B-NP	O
objects	object	NNS	I-NP	O
at	at	IN	B-PP	O
about	about	RB	B-NP	O
6	6	CD	I-NP	O
or	or	CC	I-NP	O
7	7	CD	I-NP	O
feet	foot	NNS	I-NP	O
away	away	RB	B-ADVP	O
from	from	IN	B-PP	O
him	him	PRP	B-NP	B-cell_type
.	.	.	O	O

His	His	PRP$	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
middle	middle	JJ	I-NP	O
opacification	opacification	NN	I-NP	O
concerning	concern	VBG	B-VP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
infiltrative	infiltrative	JJ	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
post	post	NN	I-NP	O
cath	cath	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
98	98	CD	B-NP	O
,	,	,	O	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
ST	ST	NN	B-NP	B-protein
elevations	elevation	NNS	I-NP	I-protein
2	2	CD	B-NP	I-protein
mm	mm	NN	I-NP	O
in	in	IN	B-PP	O
V2	V2	NN	B-NP	O
through	through	IN	B-PP	O
V3	V3	NN	B-NP	B-protein
and	and	CC	I-NP	O
ST	ST	NN	I-NP	O
depressions	depression	NNS	I-NP	O
in	in	IN	B-PP	O
leads	lead	NNS	B-NP	O
II	II	CD	I-NP	O
,	,	,	I-NP	O
III	III	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
aVF	aVF	NN	B-NP	B-protein
.	.	.	O	O

Labs	Lab	NNS	B-NP	B-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
were	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
1.4	1.4	CD	B-NP	O
up	up	RB	B-ADVP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
1.2	1.2	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
CK	CK	NN	I-NP	B-protein
of	of	IN	B-PP	O
178	178	CD	B-NP	O
and	and	CC	O	O
MB	MB	NN	B-NP	O
of	of	IN	B-PP	O
3.7	3.7	CD	B-NP	O
and	and	CC	O	O
troponin	troponin	NN	B-NP	O
of	of	IN	B-PP	O
less	less	JJR	B-NP	O
than	than	IN	B-PP	O
assay	assay	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
CBC	CBC	NN	I-NP	B-protein
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
left	left	JJ	I-NP	O
shift	shift	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
UA	UA	NN	I-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
gravity	gravity	NN	I-NP	O
of	of	IN	B-PP	O
1.086	1.086	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
+	+	SYM	I-NP	O
protein	protein	NN	I-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
glucose	glucose	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
ketones	ketone	NNS	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
blood	blood	NN	I-NP	O
,	,	,	O	O
1-3	1-3	CD	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
2-4	2-4	CD	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
trace	trace	NN	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEM	SYSTEM	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
Ischemia	Ischemia	NN	B-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
emergent	emergent	JJ	I-NP	O
cath	cath	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
on	on	IN	B-PP	O
2/18/04	2/18/04	NN	B-NP	O
showed	show	VBD	B-VP	O
two-vessel	two-vessel	JJ	B-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
LAD	LAD	NN	I-NP	O
,	,	,	O	O
osteal	osteal	JJ	B-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
marginal	marginal	JJ	I-NP	O
1	1	CD	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
LAD	LAD	NN	I-NP	O
was	be	VBD	B-VP	O
stented	stente	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
3.5	3.5	CD	I-NP	O
x	x	SYM	I-NP	O
8	8	CD	I-NP	O
mm	mm	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
3.0	3.0	CD	I-NP	O
x	x	SYM	I-NP	O
13	13	CD	I-NP	O
mm	mm	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
3.0	3.0	CD	I-NP	O
x	x	SYM	I-NP	O
18	18	CD	I-NP	O
mm	mm	NN	I-NP	O
Cipher	Cipher	NNP	I-NP	O
stents	stent	NNS	I-NP	O
all	all	DT	B-NP	O
to	to	TO	B-PP	O
0	0	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
marginal	marginal	JJ	I-NP	O
1	1	CD	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
stented	stente	VBN	I-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
cath	cath	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
CK	CK	NN	I-NP	O
peaked	peak	VBD	B-VP	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
,	,	,	I-NP	O
438	438	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
CK-MB	CK-MB	NN	I-NP	B-protein
at	at	IN	B-PP	O
452	452	CD	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
troponin	troponin	NN	I-NP	O
at	at	IN	B-PP	O
721	721	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	O
after	after	IN	B-PP	O
his	his	PRP$	B-NP	O
cath	cath	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
,	,	,	O	O
captopril	captopril	NN	B-NP	O
,	,	,	O	O
Integrilin	Integrilin	NNP	B-NP	O
x12	x12	CD	I-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
recovered	recover	VBD	B-VP	O
well	well	RB	B-ADVP	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
tachycardiac	tachycardiac	NN	B-NP	O
at	at	IN	B-PP	O
90	90	CD	B-NP	O
to	to	TO	I-NP	O
110	110	CD	I-NP	O
range	range	NN	I-NP	O
despite	despite	IN	B-PP	O
Lopressor	Lopressor	NN	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
With	With	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
tachycardia	tachycardia	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
developed	develop	VBD	B-VP	O
ST	ST	NN	B-NP	O
elevation	elevation	NN	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
aVL	aVL	NN	I-NP	O
with	with	IN	B-PP	O
ST	ST	JJ	B-NP	O
depressions	depression	NNS	I-NP	O
and	and	CC	O	O
3	3	CD	B-NP	O
aVF	aVF	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
of	of	IN	B-PP	O
3/7/04	3/7/04	CD	B-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
his	his	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
turn	turn	VB	I-VP	O
down	down	RP	B-PRT	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
second	second	JJ	I-NP	O
cath	cath	NN	I-NP	O
on	on	IN	B-PP	O
8/12/04	8/12/04	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
all	all	PDT	B-NP	O
his	his	PRP$	I-NP	O
stents	stent	NNS	I-NP	O
placed	place	VBN	B-VP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
LAD	LAD	NN	I-NP	B-protein
previously	previously	RB	B-ADVP	O
remained	remain	VBD	B-VP	O
patent	patent	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
marginal	marginal	JJ	I-NP	O
1	1	CD	I-NP	O
was	be	VBD	B-VP	O
stented	stente	VBN	I-VP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
with	with	IN	B-PP	O
Cipher	Cipher	NNP	B-NP	B-protein
stent	stent	JJ	I-NP	I-protein
0	0	CD	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
doing	do	VBG	I-VP	O
very	very	RB	B-ADVP	O
well	well	RB	I-ADVP	O
after	after	IN	B-PP	O
his	his	PRP$	B-NP	O
second	second	JJ	I-NP	O
procedure	procedure	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
remained	remain	VBD	B-VP	O
slightly	slightly	RB	B-ADJP	O
tachycardiac	tachycardiac	JJ	I-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
experienced	experience	VBD	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Pump	Pump	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
Lopressor	Lopressor	NN	B-NP	O
and	and	CC	I-NP	O
captopril	captopril	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
after	after	IN	B-SBAR	O
his	his	PRP$	B-NP	O
procedures	procedure	NNS	I-NP	O
.	.	.	O	O

Echo	Echo	NNP	B-NP	O
on	on	IN	B-PP	O
2/10/04	2/10/04	CD	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
LVEF	LVEF	NN	I-NP	B-protein
of	of	IN	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
akinesis	akinesis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
distal	distal	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
wall	wall	NN	I-NP	O
felt	feel	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
entire	entire	JJ	I-NP	O
apex	apex	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
hypokinesis	hypokinesis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
basal	basal	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
septum	septum	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
basal	basal	JJ	I-NP	O
to	to	TO	B-VP	O
mid	mid	VB	I-VP	O
lateral	lateral	JJ	B-NP	O
wall	wall	NN	I-NP	O
with	with	IN	B-PP	O
preserved	preserve	VBN	B-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
basal	basal	JJ	I-NP	O
to	to	TO	B-VP	O
mid	mid	VB	I-VP	O
inferior	inferior	JJ	B-NP	O
and	and	CC	I-NP	O
posterior	posterior	JJ	I-NP	O
wall	wall	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
apex	apex	NN	I-NP	O
is	be	VBZ	B-VP	O
near	near	RB	B-ADJP	O
aneurysmal	aneurysmal	JJ	I-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
put	put	VBN	I-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
GTT	GTT	NN	I-NP	O
given	give	VBN	B-VP	O
the	the	DT	B-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
intraventricular	intraventricular	JJ	B-NP	O
thrombus	thrombus	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
and	and	CC	I-NP	O
rate	rate	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
mildly	mildly	RB	B-ADJP	O
tachycardiac	tachycardiac	JJ	I-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
Lopressor	Lopressor	NN	I-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
for	for	IN	B-PP	O
rate	rate	NN	B-NP	O
control	control	NN	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
concerning	concern	VBG	I-NP	O
arrhythmias	arrhythmia	NNS	I-NP	O
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
sinus	sinus	NN	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
type	type	NN	B-NP	O
2	2	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
hemoglobin	hemoglobin	NN	I-NP	B-protein
A1c	A1c	NN	I-NP	O
was	be	VBD	B-VP	O
10.57	10.57	CD	B-NP	O
demonstrating	demonstrate	VBG	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
conservative	conservative	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
was	be	VBD	B-VP	O
insufficient	insufficient	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
and	and	CC	I-NP	O
insulin	insulin	NN	I-NP	B-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

Metformin	Metformin	NN	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
1/12/04	1/12/04	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
Glucotrol	Glucotrol	NN	B-NP	O
before	before	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Diabetic	Diabetic	JJ	B-NP	O
teaching	teaching	NN	I-NP	O
was	be	VBD	B-VP	O
instituted	institute	VBN	I-VP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
Mucomyst	Mucomyst	NN	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
before	before	IN	B-PP	O
and	and	CC	I-PP	O
after	after	IN	I-PP	O
both	both	DT	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
caths	cath	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
turned	turn	VBD	B-VP	O
into	into	IN	B-PP	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
1.2	1.2	CD	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
given	give	VBN	B-VP	O
his	his	PRP$	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
near	near	JJ	B-NP	O
aneurysmal	aneurysmal	JJ	I-NP	O
LV	LV	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
hypokinetic	hypokinetic	JJ	I-NP	O
apex	apex	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
in	in	IN	B-PP	O
Coumadin	Coumadin	NNP	B-NP	O
Clinic	Clinic	NNP	I-NP	O
.	.	.	O	O

Code	Code	NN	B-NP	O
status	status	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
full	full	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
febrile	febrile	JJ	B-ADJP	O
and	and	CC	O	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
middle	middle	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
five	five	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
but	but	CC	O	O
remained	remain	VBD	B-VP	O
febrile	febrile	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
tachycardiac	tachycardiac	JJ	I-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
azithromycin	azithromycin	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
five-day	five-day	JJ	B-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
defervesced	defervesce	VBN	B-VP	O
after	after	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
of	of	IN	B-PP	O
being	be	VBG	B-VP	O
on	on	IN	B-PP	O
azithromycin	azithromycin	NN	B-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
of	of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
follow-up	follow-up	JJ	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
,	,	,	O	O
was	be	VBD	B-VP	O
read	read	VBN	I-VP	O
as	as	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
having	have	VBG	B-VP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
cavitating	cavitate	VBG	I-NP	O
lesion	lesion	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
recommended	recommend	VBN	I-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
be	be	VB	B-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
following	follow	VBG	B-VP	O
medications	medication	NNS	B-NP	O
.	.	.	O	O

Enteric-coated	Enteric-coated	JJ	B-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
1/150	1/150	CD	I-NP	O
one	one	CD	I-NP	O
tab	tab	NN	I-NP	O
sublingual	sublingual	JJ	I-NP	O
q.	q.	NN	I-NP	O
5	5	CD	B-NP	O
minutes	minute	NNS	I-NP	O
x2	x2	CD	B-NP	O
doses	dose	NNS	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
azithromycin	azithromycin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	FW	I-NP	O
x4	x4	CD	I-NP	O
doses	dose	NNS	I-NP	O
,	,	,	O	O
simvastatin	simvastatin	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
metformin	metformin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Nexium	Nexium	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Toprol	Toprol	NNP	B-NP	O
XL	XL	NNP	I-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Coumadin	Coumadin	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
FOLLOW-UP	FOLLOW-UP	NN	I-NP	O
APPOINTMENTS	APPOINTMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
call	call	VB	I-VP	O
his	his	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
and	and	CC	O	O
primary	primary	JJ	B-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Budd	Budd	NNP	I-NP	O
,	,	,	O	O
within	within	IN	B-PP	O
one	one	CD	B-NP	O
to	to	TO	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Osendorf	Osendorf	NNP	I-NP	O
is	be	VBZ	B-VP	O
expecting	expect	VBG	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
call	call	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
scheduled	schedule	VBN	I-VP	O
to	to	TO	I-VP	O
go	go	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Coumadin	Coumadin	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Opa	Opa	NNP	I-NP	O
Health	Health	NNP	I-NP	O
within	within	IN	B-PP	O
five	five	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Callaway	Callaway	NNP	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
-LRB-	-LRB-	NN	B-NP	B-protein
733	733	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
394-4873	394-4873	CD	I-NP	O
was	be	VBD	B-VP	O
provided	provide	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
phone	phone	NN	I-NP	O
number	number	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
Coumadin	Coumadin	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
at	at	IN	B-PP	O
Tysco	Tysco	NNP	B-NP	O
Oolwe	Oolwe	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
.	.	.	O	O

THINGS	THINGS	NNS	B-NP	O
TO	TO	TO	B-PP	O
DO	DO	NNP	B-NP	O
AT	AT	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Romm	Romm	NNP	I-NP	O
regarding	regard	VBG	B-VP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Apple	Apple	NNP	I-NP	O
regarding	regard	VBG	B-PP	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
control	control	NN	I-NP	O
and	and	CC	O	O
possibly	possibly	RB	B-VP	O
being	be	VBG	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Mahr	Mahr	NNP	I-NP	O
regarding	regard	VBG	B-VP	O
the	the	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
cavitating	cavitate	VBG	I-NP	O
lesion	lesion	NN	I-NP	O
on	on	IN	B-PP	O
your	your	PRP$	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
doctor	doctor	NN	I-NP	O
to	to	TO	B-PP	O
phone	phone	NN	B-NP	O
with	with	IN	B-PP	O
questions	question	NNS	B-NP	O
is	be	VBZ	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Weller	Weller	NNP	I-NP	O
eScription	eScription	NN	I-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
1-6294620	1-6294620	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
RIGOTTI	RIGOTTI	NNP	B-NP	O
,	,	,	O	O
JUSTIN	JUSTIN	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
CANTINE	CANTINE	NNP	B-NP	O
,	,	,	O	O
FERNANDO	FERNANDO	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
2881940	2881940	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
3/6/04	3/6/04	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
3/6/04	3/6/04	CD	B-NP	O

